跳转至内容
Merck
CN
  • Gene expression profiling of peri-implant healing of PLGA-Li+ implants suggests an activated Wnt signaling pathway in vivo.

Gene expression profiling of peri-implant healing of PLGA-Li+ implants suggests an activated Wnt signaling pathway in vivo.

PloS one (2014-07-23)
Anna Thorfve, Anna Bergstrand, Karin Ekström, Anders Lindahl, Peter Thomsen, Anette Larsson, Pentti Tengvall
摘要

Bone development and regeneration is associated with the Wnt signaling pathway that, according to literature, can be modulated by lithium ions (Li+). The aim of this study was to evaluate the gene expression profile during peri-implant healing of poly(lactic-co-glycolic acid) (PLGA) implants with incorporated Li+, while PLGA without Li+ was used as control, and a special attention was then paid to the Wnt signaling pathway. The implants were inserted in rat tibia for 7 or 28 days and the gene expression profile was investigated using a genome-wide microarray analysis. The results were verified by qPCR and immunohistochemistry. Histomorphometry was used to evaluate the possible effect of Li+ on bone regeneration. The microarray analysis revealed a large number of significantly differentially regulated genes over time within the two implant groups. The Wnt signaling pathway was significantly affected by Li+, with approximately 34% of all Wnt-related markers regulated over time, compared to 22% for non-Li+ containing (control; Ctrl) implants. Functional cluster analysis indicated skeletal system morphogenesis, cartilage development and condensation as related to Li+. The downstream Wnt target gene, FOSL1, and the extracellular protein-encoding gene, ASPN, were significantly upregulated by Li+ compared with Ctrl. The presence of β-catenin, FOSL1 and ASPN positive cells was confirmed around implants of both groups. Interestingly, a significantly reduced bone area was observed over time around both implant groups. The presence of periostin and calcitonin receptor-positive cells was observed at both time points. This study is to the best of the authors' knowledge the first report evaluating the effect of a local release of Li+ from PLGA at the fracture site. The present study shows that during the current time frame and with the present dose of Li+ in PLGA implants, Li+ is not an enhancer of early bone growth, although it affects the Wnt signaling pathway.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
无水碳酸钠, powder, ≥99.5%, ACS reagent
Sigma-Aldrich
无水碳酸钠, ACS reagent, anhydrous, ≥99.5%, powder or granules
Sigma-Aldrich
无水碳酸钠, ACS reagent (primary standard), anhydrous, 99.95-100.05% dry basis
Sigma-Aldrich
碳酸锂, ACS reagent, ≥99.0%
Sigma-Aldrich
无水碳酸钠, ReagentPlus®, ≥99.5%
Sigma-Aldrich
无水碳酸钠, puriss., meets analytical specification of Ph. Eur., BP, NF, FCC, E500, anhydrous, 99.5-100.5% (calc. to the dried substance)
Sigma-Aldrich
苏木精
Sigma-Aldrich
无水碳酸钠, anhydrous, powder, 99.999% trace metals basis
Sigma-Aldrich
碳酸锂, puriss. p.a., ACS reagent, ≥99.0% (T)
Sigma-Aldrich
无水碳酸钠, BioXtra, ≥99.0%
Sigma-Aldrich
无水碳酸钠, anhydrous, free-flowing, Redi-Dri, ACS reagent, ≥99.5%
Sigma-Aldrich
苏木精, certified by the BSC
Supelco
碳酸钠溶液, Na2CO3 72 mM in water, IC eluent concentrate (20x) for Metrosep A Supp 7
Supelco
碳酸钠溶液, 0.1 M Na2CO3 in water, eluent concentrate for IC
Supelco
无水碳酸钠, reference material for titrimetry, certified by BAM, >99.5%
Sigma-Aldrich
碳酸锂, 99.999% trace metals basis
Sigma-Aldrich
无水碳酸钠, BioUltra, anhydrous, ≥99.5% (calc. on dry substance, T)
Sigma-Aldrich
碳酸锂, 99.997% trace metals basis
Sigma-Aldrich
无水碳酸钠, anhydrous, free-flowing, Redi-Dri, ReagentPlus®, ≥99.5%
Sigma-Aldrich
碳酸锂-7Li, ≥99 atom % 7Li, 99% (CP)
Sigma-Aldrich
无水碳酸钠, anhydrous, powder or granules, free-flowing, Redi-Dri, ACS reagent, ≥99.5%
Sigma-Aldrich
无水碳酸钠, anhydrous, free-flowing, Redi-Dri, ACS reagent (primary standard), 99.95-100.05% dry basis
Sigma-Aldrich
碳酸钠-12C, 99.9 atom % 12C
Sigma-Aldrich
无水碳酸钠, Vetec, reagent grade, ≥99.5%